Bio-Rad Laboratories (NYSE:BIO.B) Issues Quarterly Earnings Results

Bio-Rad Laboratories (NYSE:BIO.B) posted its quarterly earnings results on Thursday. The company reported $3.11 earnings per share for the quarter, Zacks reports. Bio-Rad Laboratories had a positive return on equity of 3.59% and a negative net margin of 12.37%. The business had revenue of $638.48 million during the quarter.

Bio-Rad Laboratories Price Performance

Shares of NYSE BIO.B traded up $32.55 during midday trading on Friday, reaching $326.78. 119 shares of the stock traded hands, compared to its average volume of 1,084. The company’s 50 day moving average is $285.57 and its 200 day moving average is $305.53. Bio-Rad Laboratories has a one year low of $271.00 and a one year high of $373.78. The stock has a market capitalization of $9.32 billion, a PE ratio of -31.54 and a beta of 0.72. The company has a debt-to-equity ratio of 0.13, a current ratio of 6.57 and a quick ratio of 4.89.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.